checkAd

     157  0 Kommentare BBS-Bioactive Bone Substitutes Plc has received new subscription undertakings and supplements the Investor Memorandum dated 24th of November 2023 relating to the rights offering and publishes updated Basic Information Document

    BBS-Bioactive Bone Substitutes Plc, Company Announcement, 26th of November 2023 at 6.40 p.m. EET

    BBS-Bioactive Bone Substitutes Plc has received new subscription undertakings and supplements the Investor Memorandum dated 24th of November 2023 relating to the rights offering and publishes updated Basic Information Document

    NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN PART, DIRECTLY OR INDIRECTLY, IN THE USA, AUSTRALIA, CANADA, HONG KONG, JAPAN, NEW ZEALAND, SINGAPORE OR SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE SUCH PUBLICATION OR DISTRIBUTION IS UNLAWFUL.

    BBS-Bioactive Bone Substitutes Plc ("BBS" or the "Company") has announced on 20th of November 2023 that based on authorization granted by the Extraordinary General Meeting on 23rd of October 2023, the Board of Directors of the Company has decided to arrange a rights offering totalling approximately EUR 2.63 million (the "Offering"). The Offering consists of a maximum of 6,578,481 new shares (the "Offer Shares").

    In addition to the subscription undertakings published by the Company on 24th of November 2023, the Company has received the subscription undertakings from Panvest Oy (162,000 EUR) and the Company’s CEO Juliusz Rakowski (10,000 EUR). Therefore, the total amount of subscription undertakings has reached 0.93 million euros and the certain current shareholders of the Company and two new investors have committed to subscribe for approximately 35.3 percent of the Offer Shares offered in the Offering. The Company has received the following subscription undertakings to subscribe for Offer Shares in connection with the Offering:

    Shareholder subscribing for Offer Shares Subscription undertaking (shares) Subscription undertaking (EUR)
    Municipality of Reisjärvi 831,000 332,400
    Finha Capital Oy 700,000 280,000
    Panvest Oy 405,000 162,000
    Muuraus ja Rappaus Saarimaa Oy 127,500 51,000
    Riverfort Global Opportunities PCC Limited 125,000 50,000
    Pekka Jalovaara 50,000 20,000
    Jyrki Halonen 35,000 14,000
    Juliusz Rakowski 25,000 10,000
    Jarmo Halonen 25,000 10,000
    Total 2,323,500 929,400

    Lesen Sie auch

    Seite 1 von 3



    globenewswire
    0 Follower
    Autor folgen

    Verfasst von globenewswire
    BBS-Bioactive Bone Substitutes Plc has received new subscription undertakings and supplements the Investor Memorandum dated 24th of November 2023 relating to the rights offering and publishes updated Basic Information Document BBS-Bioactive Bone Substitutes Plc, Company Announcement, 26th of November 2023 at 6.40 p.m. EET BBS-Bioactive Bone Substitutes Plc has received new subscription undertakings and supplements the Investor Memorandum dated 24th of November …